MARLBOROUGH, Mass., July 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results, business highlights and outlook for the second quarter ended June 30, 2014 on Thursday, July 24, 2014 at 8:00 a.m. ET.
The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.
A live webcast of the conference call will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.
An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.
The company will issue a news release announcing financial results for the second quarter on Thursday, July 24, 2014, prior to the conference call.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS Media: Denise Kaigler 508-683-4449 (office) Corporate Affairs & Communications Boston Scientific Corporation firstname.lastname@example.org
Investors: Susie Lisa, CFA 508-683-5565 (office) Investor Relations Boston Scientific Corporation email@example.com
SOURCE Boston Scientific Corporation